Blog Post

Blog Post

Biogen Announces Positive Results from Phase 1/2 Study of Tofersen to Treat a Genetic Form of ALS

By Sujatha Gurunathan | July 14, 2020
Blog Post

How MDA is Supporting LGMD Research and Care in 2020

By MDA Staff | July 10, 2020
Blog Post

What the COVID-19 Pandemic Can Teach Us About the Isolation Those Living With Neuromuscular Disease Experience Every Day

By Robert Paulson | July 8, 2020
Blog Post

Sarepta Therapeutics Announces Positive Results from the SRP-9001 Gene Therapy Trial to Treat DMD

By Sujatha Gurunathan | June 22, 2020
Blog Post

On World FSHD Awareness Day 2020, MDA National Ambassador Tana Zwart Asks Us to Share Our Truths

By Tana Zwart | June 19, 2020
Blog Post

Hacking COVID: MDA Staff Edition

By MDA Staff | June 18, 2020
Blog Post

Momenta Pharmaceuticals Announces Positive Results from Phase 2 Vivacity-MG Study of Nipocalimab for Treatment of Generalized Myasthenia Gravis

By Sujatha Gurunathan | June 18, 2020
Blog Post

Hacking COVID: MDA Ambassador Edition, Part 2

By MDA Staff | June 16, 2020
Dr. Stephan Züchner
Blog Post

Five Questions With CMT Researcher Stephan Züchner

By MDA Staff | June 12, 2020
Blog Post

Sarepta Therapeutics Announces Positive Results from the SRP-9003 Gene Therapy Trial to Treat LGMD2E

By Sujatha Gurunathan | June 11, 2020